Furthermore, it has been shown that phospho-BIN1(T348):BIN1 ratio was increased in post-mortem AD brain samples, suggesting a compensatory mechanism to counteract hyper-phosphorylated Tau toxicity[32]. Here, MAPT is linked to Alzheimer disease.